SEC Filings
Astera Labs Director Michael Hurlston Resigns From Board, Citing No Dispute With The Company
The company says the departure was not tied to any disagreement or to its operations, policies or practices.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
SEC Filings
The company says the departure was not tied to any disagreement or to its operations, policies or practices.
Earnings
The software maker also raised 2026 guidance, with drug discovery revenue now seen at $75 million to $85 million.
SEC Filings
The bank's investor deck also keeps its 2026 outlook unchanged, including net interest income of about $2,400 million, plus or minus 2%.
Earnings
Partner cost recoveries cut Vir's third-quarter R&D to $80.0 million while cash fell to about $901.3 million before a $90.0 million Gilead payment.
Earnings
The CFO said revenue per test fell because payers pay nothing on more claims, even as Myriad agreed to sell its prenatal unit for $210 million.
SEC Filings
The fiber-optics maker paid a $350,000 fee to end its prior loan and opened a four-year facility with room for $50 million more.
Markets
CMS's final 2027 physician fee schedule also lets approved ACOs cut Part B cost-sharing from April 1, 2027.
Markets
Conversion factors still fall for 2027, and a remote-monitoring staffing limit is pushed back to Jan. 1, 2029.
Markets
The agency projects the changes would add up to 1 million assigned beneficiaries in an average year and lift net federal savings by $5.5 billion.
Deals
A laser annealing system is stuck at U.S. Customs, and Veeco has not asked the buyer to pay while its Axcelis merger waits on China.
Markets
CMS's final 2027 outpatient rule also extends lower imaging rates and adds eight botulinum toxin codes to prior authorization.
Markets
The final 2027 outpatient rule cuts drug payments by $4.35 billion in year one and shifts the money to non-drug services.